PCR parameters consisted of an initial denaturation step at 95°C for 8 minutes, followed by 35 cycles of 94°C for 1 minute, 60°C for 1 minute, and 72°C for 1 minute, and finally 8 minutes at 72°C.
To identify MTHFR c.677C>T and c.1298A>C, HinfI and MboII restriction enzyme were used, respectively, in separate tubes.
A 3% agarose gel electrophoresis was performed at 80 V during 20 minutes. The amplicons from PCR and PCR-RFLP were visualized by ethidium bromide under an UV transilluminator.
To validate our newly developed multiplex PCR, DNA samples were randomly selected for sequencing.
| RESULTS
In the present study, we established a duplex PCR-RFLP assay to detect both variants of MTHFR. Several factors, such as primer concentration and PCR cycling condition, were optimized. Among our study, eight patients were heterozygous for c.677C>T
of MTHFR (677CT) with an overall frequency of 16% ( Figure 3 ).
| DISCUSSION
We have successfully developed a new and simple method for the simultaneous detection of the MTHFR c.677C>T and c.1298A>C and genotyping of 50 patients with AL.
For diagnostic analysis of a large number of patients, the fast and economic assay is highly desirable. Thus, a number of molecular approaches targeting genomic DNA for identification of both polymorphisms have also been developed (Table 1) . These include different types of conventional PCR, real-time PCR, and DNA sequencing. [10] [11] [12] All of these techniques are fast and elegant, but they require expensive equipment. Because of their cost and complexity, they might be not used routinely in some medical environments.
Our assay presents several main advantages. Firstly, a one step amplification for both SNPs, secondly, no special equipment is used, and thirdly the results are stable and reproducible. Both variants were screened in the AL patients. Interestingly, we have eight heterozygous 677 CT of MTHFR cases with an overall frequency of 16%. This result highlights the possible impact of C677T polymorphism on the risk of AL, however, never MTHFR c.1298A>C
(as 1298 AC or 1298 CC) was found (0%).
In fact, it has been proved that the MTHFR 677TT genotype conferred a significant higher risk of leukemia. 13 In addition, MTHFR 677TT genotype may be associated with elevated risk of adverse effects during Methotrexate treatment of AL patients. 14 
| CONCLUSION
This duplex PCR-RFLP provided an early and accurate diagnosis of the MTHFR c.677C>T and c.1298A>C; hence it may be used as an alternative method to the conventional gold technique for the rapid genotyping of MTHFR polymorphisms in acute leukemia.
